Anti-CD19 BITE Blinatumomab Induces High Complete Remission Rate In Adult Patients with Relapsed B-Precursor ALL: Updated Results of An Ongoing Phase II Trial

Topp, Max S. and Goekbuget, Nicola and Zugmaier, Gerhard and Viardot, Andreas and Stelljes, Matthias and Neumann, Svenja and Horst, Heinz A. and Reichle, Albrecht and Marks, Reinhard E. and Brueggemann, Monika and Ritgen, Matthias and Klappers, Petra and Mergen, Noemi and Goebeler, Marie-Elisabeth and Einsele, Hermann and Hoelzer, Dieter and Bargou, Ralf (2011) Anti-CD19 BITE Blinatumomab Induces High Complete Remission Rate In Adult Patients with Relapsed B-Precursor ALL: Updated Results of An Ongoing Phase II Trial. BLOOD, 118 (21): 252. p. 115. ISSN 0006-4971

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User: Petra Gürster
Date Deposited: 06 May 2020 10:01
Last Modified: 06 May 2020 10:01
URI: https://pred.uni-regensburg.de/id/eprint/19794

Actions (login required)

View Item View Item